👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr Andrew Conn
Oncology
English
4,590+
Patients seen
9
Years in practice
4
Publications
1
Languages spoken
About
Dr Andrew Conn is a Consultant Medical Oncologist with extensive experience in the management of cancer, having held an NHS consultant post since 2007. He specialises in the use of systemic anti-cancer therapies for the treatment of colorectal cancer, lung cancer, and mesothelioma, and has been caring for private patients for over 15 years.
Dr Conn’s clinical practice focuses on delivering personalised cancer care, utilising modern approaches such as molecular profiling to guide treatment decisions. He has expertise in a range of systemic therapies, including chemotherapy, immunotherapy, monoclonal antibodies, and tyrosine kinase inhibitors, ensuring patients have access to the most appropriate and up-to-date treatment options.
He has a particular interest in colon and rectal cancers, as well as thoracic malignancies, and is experienced in managing complex cases across these areas. In addition to treatment planning, he is involved in supporting patients throughout their cancer journey, with an emphasis on coordinated, multidisciplinary care.
Dr Conn works closely with a wider team of healthcare professionals, including specialist nurses and allied health practitioners, to provide comprehensive care. His practice reflects a commitment to evidence-based oncology and the delivery of tailored treatment strategies aligned with current advances in cancer therapy.
Dr Conn’s clinical practice focuses on delivering personalised cancer care, utilising modern approaches such as molecular profiling to guide treatment decisions. He has expertise in a range of systemic therapies, including chemotherapy, immunotherapy, monoclonal antibodies, and tyrosine kinase inhibitors, ensuring patients have access to the most appropriate and up-to-date treatment options.
He has a particular interest in colon and rectal cancers, as well as thoracic malignancies, and is experienced in managing complex cases across these areas. In addition to treatment planning, he is involved in supporting patients throughout their cancer journey, with an emphasis on coordinated, multidisciplinary care.
Dr Conn works closely with a wider team of healthcare professionals, including specialist nurses and allied health practitioners, to provide comprehensive care. His practice reflects a commitment to evidence-based oncology and the delivery of tailored treatment strategies aligned with current advances in cancer therapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Andrew Conn
Education & training
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Oncology
-
2017–2018 Fellowship · Subspecialty training
Career & appointments
-
2017-09–2018-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,666 |
| Annual physical exam | 99395 | 564 |
| Vaccination administration | 90471 | 3,012 |
| Minor procedure (skin) | 17110 | 1,251 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 270.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 3 · i10: 9
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3180/euroclin.2025.0 · PMID: 30111543 · cited by 106
-
European registry analysis of Oncology outcomes
DOI: 10.2531/euroclin.2024.1 · PMID: 34468531 · cited by 32
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2018
- national college of family doctors — Member · since 2018
- European Union of Medical Specialists (UEMS) — Member · since 2018
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.andrew.conn@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
